Martin Francis Flajnik (Q138692): Difference between revisions
From geokb
(Created a new Item: Person record added from ORCID registry based on ORCID ID found as author/contributor to USGS publication) |
(Changed an Item: added Wikidata same as link) |
||||||||||||||
(6 intermediate revisions by the same user not shown) | |||||||||||||||
Property / instance of: person / reference | |||||||||||||||
Property / ORCID iD | |||||||||||||||
Property / ORCID iD: 0000-0002-2792-5084 / rank | |||||||||||||||
Property / ORCID iD: 0000-0002-2792-5084 / reference | |||||||||||||||
Property / ORCID iD | |||||||||||||||
Property / ORCID iD: 0000-0002-2792-5084 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / ORCID iD: 0000-0002-2792-5084 / qualifier | |||||||||||||||
retrieved: 22 January 2024
| |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Regulatory T Cell Development and Function / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Regulatory T Cell Development and Function / qualifier | |||||||||||||||
last update: 20 August 2024
| |||||||||||||||
Property / knows about: Regulatory T Cell Development and Function / qualifier | |||||||||||||||
prevalence: 55
| |||||||||||||||
Property / knows about: Regulatory T Cell Development and Function / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Natural Killer Cells in Immunity / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Natural Killer Cells in Immunity / qualifier | |||||||||||||||
last update: 20 August 2024
| |||||||||||||||
Property / knows about: Natural Killer Cells in Immunity / qualifier | |||||||||||||||
prevalence: 30
| |||||||||||||||
Property / knows about: Natural Killer Cells in Immunity / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Immunological Responses in Aquatic Organisms / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Immunological Responses in Aquatic Organisms / qualifier | |||||||||||||||
last update: 20 August 2024
| |||||||||||||||
Property / knows about: Immunological Responses in Aquatic Organisms / qualifier | |||||||||||||||
prevalence: 24
| |||||||||||||||
Property / knows about: Immunological Responses in Aquatic Organisms / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Therapeutic Antibodies: Development, Engineering, and Applications / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Therapeutic Antibodies: Development, Engineering, and Applications / qualifier | |||||||||||||||
last update: 20 August 2024
| |||||||||||||||
Property / knows about: Therapeutic Antibodies: Development, Engineering, and Applications / qualifier | |||||||||||||||
prevalence: 21
| |||||||||||||||
Property / knows about: Therapeutic Antibodies: Development, Engineering, and Applications / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Innate Immune Recognition and Signaling Pathways / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Innate Immune Recognition and Signaling Pathways / qualifier | |||||||||||||||
last update: 20 August 2024
| |||||||||||||||
Property / knows about: Innate Immune Recognition and Signaling Pathways / qualifier | |||||||||||||||
prevalence: 14
| |||||||||||||||
Property / knows about: Innate Immune Recognition and Signaling Pathways / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Glycosylation in Health and Disease / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Glycosylation in Health and Disease / qualifier | |||||||||||||||
last update: 20 August 2024
| |||||||||||||||
Property / knows about: Glycosylation in Health and Disease / qualifier | |||||||||||||||
prevalence: 14
| |||||||||||||||
Property / knows about: Glycosylation in Health and Disease / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Immunobiology of Dendritic Cells / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Immunobiology of Dendritic Cells / qualifier | |||||||||||||||
last update: 20 August 2024
| |||||||||||||||
Property / knows about: Immunobiology of Dendritic Cells / qualifier | |||||||||||||||
prevalence: 13
| |||||||||||||||
Property / knows about: Immunobiology of Dendritic Cells / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Innate Immunity to Viral Infection / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Innate Immunity to Viral Infection / qualifier | |||||||||||||||
last update: 20 August 2024
| |||||||||||||||
Property / knows about: Innate Immunity to Viral Infection / qualifier | |||||||||||||||
prevalence: 9
| |||||||||||||||
Property / knows about: Innate Immunity to Viral Infection / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Integrin Signaling in Inflammation and Cancer / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Integrin Signaling in Inflammation and Cancer / qualifier | |||||||||||||||
last update: 20 August 2024
| |||||||||||||||
Property / knows about: Integrin Signaling in Inflammation and Cancer / qualifier | |||||||||||||||
prevalence: 9
| |||||||||||||||
Property / knows about: Integrin Signaling in Inflammation and Cancer / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Ubiquitin-Proteasome Proteolytic Pathway / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Ubiquitin-Proteasome Proteolytic Pathway / qualifier | |||||||||||||||
last update: 20 August 2024
| |||||||||||||||
Property / knows about: Ubiquitin-Proteasome Proteolytic Pathway / qualifier | |||||||||||||||
prevalence: 8
| |||||||||||||||
Property / knows about: Ubiquitin-Proteasome Proteolytic Pathway / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Invertebrate Immunity and Host Defense Mechanisms / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Invertebrate Immunity and Host Defense Mechanisms / qualifier | |||||||||||||||
last update: 20 August 2024
| |||||||||||||||
Property / knows about: Invertebrate Immunity and Host Defense Mechanisms / qualifier | |||||||||||||||
prevalence: 7
| |||||||||||||||
Property / knows about: Invertebrate Immunity and Host Defense Mechanisms / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Role of Complement System in Immune Response / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Role of Complement System in Immune Response / qualifier | |||||||||||||||
last update: 20 August 2024
| |||||||||||||||
Property / knows about: Role of Complement System in Immune Response / qualifier | |||||||||||||||
prevalence: 7
| |||||||||||||||
Property / knows about: Role of Complement System in Immune Response / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Prediction of Peptide-MHC Binding Affinity / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Prediction of Peptide-MHC Binding Affinity / qualifier | |||||||||||||||
last update: 20 August 2024
| |||||||||||||||
Property / knows about: Prediction of Peptide-MHC Binding Affinity / qualifier | |||||||||||||||
prevalence: 6
| |||||||||||||||
Property / knows about: Prediction of Peptide-MHC Binding Affinity / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Role of Chemokine Receptors in Cancer Metastasis / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Role of Chemokine Receptors in Cancer Metastasis / qualifier | |||||||||||||||
last update: 20 August 2024
| |||||||||||||||
Property / knows about: Role of Chemokine Receptors in Cancer Metastasis / qualifier | |||||||||||||||
prevalence: 5
| |||||||||||||||
Property / knows about: Role of Chemokine Receptors in Cancer Metastasis / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Role of Galectins in Immunity and Disease / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Role of Galectins in Immunity and Disease / qualifier | |||||||||||||||
last update: 20 August 2024
| |||||||||||||||
Property / knows about: Role of Galectins in Immunity and Disease / qualifier | |||||||||||||||
prevalence: 5
| |||||||||||||||
Property / knows about: Role of Galectins in Immunity and Disease / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Genetic Basis of Primary Immunodeficiency Disorders / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Genetic Basis of Primary Immunodeficiency Disorders / qualifier | |||||||||||||||
last update: 20 August 2024
| |||||||||||||||
Property / knows about: Genetic Basis of Primary Immunodeficiency Disorders / qualifier | |||||||||||||||
prevalence: 5
| |||||||||||||||
Property / knows about: Genetic Basis of Primary Immunodeficiency Disorders / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Zebrafish as a Model Organism for Multidisciplinary Research / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Zebrafish as a Model Organism for Multidisciplinary Research / qualifier | |||||||||||||||
last update: 20 August 2024
| |||||||||||||||
Property / knows about: Zebrafish as a Model Organism for Multidisciplinary Research / qualifier | |||||||||||||||
prevalence: 3
| |||||||||||||||
Property / knows about: Zebrafish as a Model Organism for Multidisciplinary Research / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Immunological Mechanisms in Atherosclerosis Development / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Immunological Mechanisms in Atherosclerosis Development / qualifier | |||||||||||||||
last update: 20 August 2024
| |||||||||||||||
Property / knows about: Immunological Mechanisms in Atherosclerosis Development / qualifier | |||||||||||||||
prevalence: 3
| |||||||||||||||
Property / knows about: Immunological Mechanisms in Atherosclerosis Development / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Epidemiology and Management of Neuroendocrine Tumors / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Epidemiology and Management of Neuroendocrine Tumors / qualifier | |||||||||||||||
last update: 20 August 2024
| |||||||||||||||
Property / knows about: Epidemiology and Management of Neuroendocrine Tumors / qualifier | |||||||||||||||
prevalence: 3
| |||||||||||||||
Property / knows about: Epidemiology and Management of Neuroendocrine Tumors / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: DNA Nanotechnology and Bioanalytical Applications / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: DNA Nanotechnology and Bioanalytical Applications / qualifier | |||||||||||||||
last update: 20 August 2024
| |||||||||||||||
Property / knows about: DNA Nanotechnology and Bioanalytical Applications / qualifier | |||||||||||||||
prevalence: 3
| |||||||||||||||
Property / knows about: DNA Nanotechnology and Bioanalytical Applications / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Molecular Chaperones in Protein Folding and Disease / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Molecular Chaperones in Protein Folding and Disease / qualifier | |||||||||||||||
last update: 20 August 2024
| |||||||||||||||
Property / knows about: Molecular Chaperones in Protein Folding and Disease / qualifier | |||||||||||||||
prevalence: 2
| |||||||||||||||
Property / knows about: Molecular Chaperones in Protein Folding and Disease / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Role of Neutrophil Extracellular Traps in Immunity / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Role of Neutrophil Extracellular Traps in Immunity / qualifier | |||||||||||||||
last update: 20 August 2024
| |||||||||||||||
Property / knows about: Role of Neutrophil Extracellular Traps in Immunity / qualifier | |||||||||||||||
prevalence: 2
| |||||||||||||||
Property / knows about: Role of Neutrophil Extracellular Traps in Immunity / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Conservation of Sharks and Rays / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Conservation of Sharks and Rays / qualifier | |||||||||||||||
last update: 20 August 2024
| |||||||||||||||
Property / knows about: Conservation of Sharks and Rays / qualifier | |||||||||||||||
prevalence: 2
| |||||||||||||||
Property / knows about: Conservation of Sharks and Rays / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Role of Matrix Metalloproteinases in Cancer and Physiology / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Role of Matrix Metalloproteinases in Cancer and Physiology / qualifier | |||||||||||||||
last update: 20 August 2024
| |||||||||||||||
Property / knows about: Role of Matrix Metalloproteinases in Cancer and Physiology / qualifier | |||||||||||||||
prevalence: 2
| |||||||||||||||
Property / knows about: Role of Matrix Metalloproteinases in Cancer and Physiology / reference | |||||||||||||||
Property / knows about | |||||||||||||||
Property / knows about: Global Amphibian Declines and Extinctions / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / knows about: Global Amphibian Declines and Extinctions / qualifier | |||||||||||||||
last update: 20 August 2024
| |||||||||||||||
Property / knows about: Global Amphibian Declines and Extinctions / qualifier | |||||||||||||||
prevalence: 2
| |||||||||||||||
Property / knows about: Global Amphibian Declines and Extinctions / reference | |||||||||||||||
Property / OpenAlex ID | |||||||||||||||
Property / OpenAlex ID: A5043201622 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / OpenAlex ID: A5043201622 / qualifier | |||||||||||||||
last update: 20 August 2024
| |||||||||||||||
Property / OpenAlex ID: A5043201622 / qualifier | |||||||||||||||
retrieved: 29 August 2024
| |||||||||||||||
Property / employer | |||||||||||||||
Property / employer: University of Maryland, Baltimore / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / employer: University of Maryland, Baltimore / qualifier | |||||||||||||||
point in time: 2024
| |||||||||||||||
Property / employer: University of Maryland, Baltimore / reference | |||||||||||||||
Property / same as | |||||||||||||||
Property / same as: http://www.wikidata.org/entity/Q30504281 / rank | |||||||||||||||
Normal rank |
Latest revision as of 16:08, 4 October 2024
a record for a person added from ORCID based on a contributor to a USGS publication
- Flajnik MF
Language | Label | Description | Also known as |
---|---|---|---|
English | Martin Francis Flajnik |
a record for a person added from ORCID based on a contributor to a USGS publication |
|
Statements
20 August 2024
55
1 reference
20 August 2024
30
1 reference
20 August 2024
24
1 reference
20 August 2024
21
1 reference
20 August 2024
14
1 reference
20 August 2024
14
1 reference
20 August 2024
13
1 reference
20 August 2024
1 reference
20 August 2024
1 reference
20 August 2024
1 reference
20 August 2024
1 reference
20 August 2024
1 reference
20 August 2024
1 reference
20 August 2024
1 reference
20 August 2024
1 reference
20 August 2024
1 reference
20 August 2024
1 reference
20 August 2024
1 reference
20 August 2024
1 reference
20 August 2024
1 reference
20 August 2024
1 reference
20 August 2024
1 reference
20 August 2024
1 reference
1 reference
20 August 2024
1 reference